Abstract
The purpose of this review is to address the role of the scientific excellence of innovative medicines as the key element in the development process in Greece. The collected statistical information and data on the absorbability of funds for research of innovative medicines, diagnostics, and advanced drug delivery systems pointed out that the Greek scientists could take advantage of the "Horizon 2020" on the continuity of their investigation, whilst how the accumulation of knowledge at Greek universities and research foundations could be translated into industrial products with added value, safe and effective for the European consumers. In conclusion, this review also is considered to provide the potential benefits in order to adapt the signaling of the "Horizon 2020" for the development of a bio-better Europe based on scientific inspirations. This approach could be considered as an interplay between countries and even between the north and west located countries in the European landscape.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
